Atypical behavioural responses to CCK-B receptor ligands in Fawn-Hooded rats

Life Sciences

Volumn 74, Issue 1, 2003, Pages 1-12

  Lodge, Daniel J ^a   Roques, Bernard P ^b   Lawrence, Andrew J ^a  

^a MONASH UNIVERSITY   (Australia)

^b CNRS   (France)

Author keywords

Anxiety; CCK B1; CCK B2; FH rat; Receptor heterogeneity

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; BC 264; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR AGONIST; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; DEVAZEPIDE; LIGAND; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; IN VITRO STUDY; LABORATORY; MALE; NEUROCHEMISTRY; NONHUMAN; RAT; RAT STRAIN; TRANQUILIZING ACTIVITY;

EID: 0142248481     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.03.003     Document Type: Article

References (42)

1. Bellier B., Mccort-Tranchepain I., Ducos B., Danascimento S., Meudal H., Noble F., Garbay C., Roques B.P. Synthesis and biological properties of new constrained CCK-B antagonists: Discrimination of two affinity states of the CCK-B receptor on transfected cho cells. Journal of Medicinal Chemistry. 40:1997;3947-3956.
2. Bradwejn J., Koszycki D. The cholecystokinin hypothesis of anxiety and panic disorder. Annals of the New York Academy of Sciences. 713:1994;273-282.
3. 28,31]CCK-(25-33): A convenient new aminopeptidase resistant cholecystokinin analogue for radioligand binding and autoradiography. European Journal of Pharmacology. 191:1990;107-110.
4. Crawley J.N. Cholecystokinin-dopamine interactions. Trends in Pharmacological Sciences. 12:1991;232-236.
5. Derrien M., Mccort-Tranchepain I., Ducos B., Roques B.P., Durieux C. Heterogeneity of CCK-B receptors involved in animal models of anxiety. Pharmacology, Biochemistry & Behavior. 49:1994;133-141.
6. Durieux C., Coppey M., Zajac J.M., Roques B.P. Occurrence of two cholecystokinin binding sites in guinea-pig brain cortex. Biochemical & Biophysical Research Communications. 137:1986;1167-1173.
7. 3H]SNF 8702. Molecular Pharmacology. 41:1992;1089-1095.
8. Fossa A.A., Depasquale M.J., Morrone J., Zorn S.H., Bryce D., Lowe J.A., Mclean S. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-b receptor subtype in the conscious guinea pig and dog. Journal of Pharmacology & Experimental Therapeutics. 281:1997;180-187.
9. 3H]pentagastrin. Peptides. 4:1983;755-762.
10. Gillis R.A., Quest J.A., Pagani F.D., Souza J.D., Da Silva A.M., Jensen R.T., Garvey T.Q.D., Hamosh P. Activation of central nervous system cholecystokinin receptors stimulates respiration in the cat. Journal of Pharmacology & Experimental Therapeutics. 224:1983;408-414.
11. Griebel G. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? Pharmacology & Therapeutics. 82:1999;1-61.
12. Handley S.L., Mithani S. Effects of α-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmiedebergs Archives of Pharmacology. 327:1984;1-5.
13. Harper E.A., Griffin E.P., Shankley N.P., Black J.W. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex. British Journal of Pharmacology. 126:1999;1496-1503.
14. Harper E.A., Shankley N.P., Black J.W. Characterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortex. British Journal of Pharmacology. 126:1999;1504-1512.
15. Innis R.B., Synder S.H. Cholecystokinin receptor binding in brain and pancreas: Regulation of pancreatic binding by cyclic and acyclic guanine nucleotides. European Journal of Pharmacology. 65:1980;123-124.
16. Koob G.F. Neural mechanisms of drug reinforcement. Annals of the New York Academy of Sciences. 654:1992;171-191.
17. Ladurelle N., Sebret A., Garbay C., Roques B.P., Dauge V. Opposite effects of CCKB agonists in grooming behaviour in rats: Further evidence for two CCKB subsites. British Journal of Pharmacology. 124:1998;1091-1098.
18. Lança A.J., De Cabo C., Arifuzzaman A.I., Vaccarino F.J. Cholecystokinergic innervation of nucleus accumbens subregions. Peptides. 19:1998;859-868.
19. Lena I., Roques B.P., Durieux C. Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites. Journal of Neurochemistry. 68:1997;162-168.
20. Lena I., Simon H., Roques B.P., Dauge V. Opposing effects of two CCKB agonists on the retrieval phase of a two-trial memory task after systemic injection in the rat. Neuropharmacology. 38:1999;543-553.
21. Lodge D.J., Lawrence A.J. Comparative analysis of the central CCK system in Fawn Hooded and Wistar Kyoto rats: Extended localisation of CCK-A receptors throughout the rat brain using a novel radiologand. Regulatory Peptides. 99:2001;191-201.
22. Lodge D.J., Lawrence A.J. The effect of isolation rearing on volitional ethanol consumption and central CCK/dopamine systems in Fawn-Hooded rats. Behavioural Brain Research. 141:2003;113-122.
23. Lodge D.J., Short J.L., Mercer L.D., Beart P.M., Lawrence A.J. CCK/dopamine interactions in Fawn-Hooded and Wistar-Kyoto rat brain. Peptides. 21:2000;379-386.
24. Marshall F.H., Barnes S., Hughes J., Woodruff G.N., Hunter J.C. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. Journal of Neurochemistry. 56:1991;917-922.
25. Matto V., Harro J., Allikmets L. The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat. Neuropharmacology. 36:1997;389-396.
26. National Health and Medical Research Council (Aus) Australian code of practice for the care and use of animals for scientific purposes. 6th ed. 1997.
27. Ramos A., Berton O., Mormede P., Chaouloff F. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behavioural Brain Research. 85:1997;57-69.
28. Rehfeld J.F. CCK and anxiety. Dourish C.T., Cooper S.J., Iversen S.D., Iversen L.L. 1992;117-120 Oxford University Press, London.
29. Rex A., Barth T., Voigt J.P., Domeney A.M., Fink H. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety. Neuroscience Letters. 172:1994;139-142.
30. Rex A., Fink H., Marsden C.A. Effects of boc-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze. Neuropharmacology. 33:1994;559-565.
31. Rezvani A.H., Grady D.R. Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction. Pharmacology, Biochemistry & Behavior. 48:1994;105-110.
32. Rezvani A.H., Parsian A., Overstreet D.H. The Fawn-Hooded (FH/WJD) rat: A genetic animal model of comorbid depression and alcoholism. Psychiatric Genetics. 12:2002;1-16.
33. Seroogy K.B., Dangaran K., Lim S., Haycock J.W., Fallon J.H. Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions. Journal of Comparative Neurology. 279:1989;397-414.
34. Seroogy K.B., Fallon J.H. Forebrain projections from cholecystokininlike- immunoreactive neurons in the rat midbrain. Journal of Comparative Neurology. 279:1989;415-435.
35. Singh L., Field M.J., Hughes J., Menzies R., Oles R.J., Vass C.A., Woodruff G.N. The behavioural properties of CI-988, a selective cholecystokinin-B receptor antagonist. British Journal of Pharmacology. 104:1991;239-245.
36. Singh L., Lewis A.S., Field M.J., Hughes J., Woodruff G.N. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proceedings of the National Academy of Sciences of the United States of America. 88:1991;1130-1133.
37. Sprang S.R., Coleman D.E. Invasion of the nucleotide snatchers: Structural insights into the mechanism of G protein GEFs. Cell. 95:1998;155-158.
38. Vaccarino F.J., Vaccarino A.L. Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: Differential effects on brain stimulation reward. Neuroscience Letters. 97:1989;151-156.
39. Vanderhaeghen J.J., Signeau J.C., Gepts W. New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature. 257:1975;604-605.
40. 3H]dopamine efflux from rat nucleus accumbens. Neuropeptides. 13:1989;43-50.
41. Wennogle L.P., Steel D.J., Petrack B. Characterization of central cholecystokinin receptors using a radioiodinated octapeptide probe. Life Sciences. 36:1985;1485-1492.
42. Woods S.C., Seeley R.J., Porte D. Jr., Schwartz M.W. Signals that regulate food intake and energy homeostasis. Science. 280:1998;1378-1383.